This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Orion Corporation. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Veli Pekka Tanninen: Innovator in Pyridazinone Derivatives
Introduction
Veli Pekka Tanninen is a notable inventor based in Espoo, Finland. He has made significant contributions to the field of chemistry, particularly in the development of methods for obtaining pure enantiomers of pyridazinone derivatives. His work is recognized for its potential applications in pharmaceuticals and other industries.
Latest Patents
Tanninen holds a patent for a method titled "Method for obtaining pure enantiomers of a pyridazinone derivative." This invention relates to a method for preparing optically active enantiomers of a specific compound, particularly focusing on the (-) enantiomer. Additionally, the patent introduces a novel crystalline polymorphic form of the (-) enantiomer, showcasing Tanninen's innovative approach to chemical synthesis. He has 1 patent to his name.
Career Highlights
Veli Pekka Tanninen is associated with Orion Corporation, a prominent company in the pharmaceutical industry. His work at Orion has allowed him to explore and develop new methodologies that enhance the purity and efficacy of chemical compounds. His contributions have been instrumental in advancing the company's research and development efforts.
Collaborations
Throughout his career, Tanninen has collaborated with esteemed colleagues such as Mika Timmerbacka and Esa Muttonen. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.
Conclusion
Veli Pekka Tanninen is a distinguished inventor whose work in the field of pyridazinone derivatives has made a lasting impact. His innovative methods and collaborations continue to influence the pharmaceutical industry and contribute to advancements in chemical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
